US drugmaker AbbVie has signed an agreement to acquire biotechnology company Aliada Therapeutics, which develops therapies for central nervous system (CNS) diseases using...
03.09.2015
- Swiss drugmaker Novartis has announced it will cooperate with US biopharmaceutical group Amgen to develop and sell neuroscience treatments for conditions such as Alzheimer's...
